An opinion - when IME cranks up the global repeat/repeat/repeat/ revenue streams in world health organisations, buyers such as institutions with serious funds will shove a rocket up the existing share price.
A high octane health business model with low overheads, cloud-based and evolving AI technologies
Institutions with millions of dollars to place will have IME on their radar, mark my words.
The action with this global health technology stock is in its infancy......watch
IME Price at posting:
$1.55 Sentiment: Buy Disclosure: Held
